Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-021346

President and CEO bought 8,090 shares at $12.40 ($100,316)

From the SEC's structured data for this filing

Trades in this filing

AHMED NADIM · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-06-06 Purchase : show line 1 in the form +8,090 $12.40 $100,316 8,090 D
Open-market purchases · 8,090 sh · avg $12.40 · $100,316
Loading xslF345X03/doc4.xml…